DarioHealth (DRIO) Net Equity Issued and Repurchased (2013 - 2022)

DarioHealth (DRIO) has reported Net Equity Issued and Repurchased for 5 consecutive years, with $265000.0 the latest figure, recorded in Q4 2022.

• For the quarter ending Q4 2022, Net Equity Issued and Repurchased changed N/A year-over-year to $265000.0; the trailing twelve-month figure through Dec 2022 stood at $38.3 million (down 40.98% YoY), and the FY2022 full-year result was $38.3 million, down 40.98% from the prior year.
• Net Equity Issued and Repurchased eased to $265000.0 in Q4 2022 per DRIO's latest filing, from $38.0 million in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $64.9 million in Q1 2021 and bottomed at $265000.0 in Q4 2022.
• Historically, Net Equity Issued and Repurchased has averaged $29.9 million across 4 years, with a median of $27.5 million in 2020.
• The widest YoY moves for Net Equity Issued and Repurchased: up 41.39% in 2022, down 41.39% in 2022.
• Over 4 years, Net Equity Issued and Repurchased stood at $18.7 million in 2019, then soared by 47.4% to $27.5 million in 2020, then surged by 135.51% to $64.9 million in 2021, then tumbled by 99.59% to $265000.0 in 2022.
• According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $265000.0, $38.0 million, and $64.9 million for Q4 2022, Q1 2022, and Q1 2021 respectively.